IC-223 Demodex Blepharitis: Prevalence, Burden and Current Scientific Evidence | ASCRS
Menu
Home Clinical Education Presentations On Demand On-Demand Programs 2022 ASCRS Annual Meeting Sessions IC-223 Demodex Blepharitis: Prevalence, Burden and Current Scientific Evidence
Session
IC-223 Demodex Blepharitis: Prevalence, Burden and Current Scientific Evidence
April 2022
Meeting: 2022 ASCRS Annual Meeting
Course Instructor: Eric D. Rosenberg, DO, MSE
Co-Instructors: Elizabeth Yeu, MD, Laura M. Periman, MD, ABO, William B. Trattler, MD, ABO, Mitchell A. Jackson, MD, ABO, Usiwoma Abugo, MD, ABO, Helen K. Wu, MD, ABO
< Browse All 2022 Instructional Courses
This content is only available for ASCRS Members

ASCRS Membership offers access to 1,000+ educational resources on demand.

Course Description
 This course will review and highlight the clinical relevance of Demodex blepharitis (DB) among eye care patients. Through video and case studies, the audience will be able to more confidently identify blepharitis and identify DB via collarettes, the pathognomonic sign of Demodex blepharitis. Clinical burden, risk factors, comorbid diseases, and latest scientific evidence on current and emerging treatments for DB will be explored.

Educational Objective
Use a systematic approach to improve management of Demodex blepharitis and lid health

Filed Under
Cornea 2022 Instructional Course blepharitis
2022 ASCRS Annual Meeting Instructional Courses

This 1.5 hour Instructional Course was recorded at the 2022 ASCRS Annual Meeting in Washington, DC on April 22-25. 

Browse All 2022 On Demand Courses
American
About ASCRS
Clinical Education
Meetings
Tools
ASCRS foundation
Donate
Contact Us

© 2024 ASCRS. All Rights Reserved.

Advertise Legal Notice

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.